ClinicalTrials.Veeva

Menu

Novel Biomarkers in Chronic Airway Diseases

C

Chonbuk National University

Status

Unknown

Conditions

Asthma
COPD

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is:

  • To define The differences of bio-chemical phenotypes in chronic airway inflammatory diseases.
  • To identify novel biomarkers in chronic airway inflammatory diseases as a screening, diagnostic, or monitoring marker.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • > 18 years olds
  • Both sexes
  • Asthma or COPD was diagnosed according to the criteria of the American Thoracic Society, GINA, GOLD guideline
  • Acute exacerbation was defined by the criteria of the American Thoracic Society, GINA, GOLD guideline
  • For stable disease, none of the subjects had received inhaled or oral corticosteroids or any other anti-inflammatory drugs, had an exacerbation history in the previous 6 months

Trial design

30 participants in 3 patient groups

Acute exacerbation
Stable disease
Healthy control

Trial contacts and locations

1

Loading...

Central trial contact

Yong Chul Lee, MD, PhD; So Ri Kim, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems